SUMMIT BIOMEDICAL IMAGING LLC
PARPi FL optical imaging agent for intraoperative margin assessment of cervical and vulvar dysplasia and cancer
- Sector
- Medtech
- Headquarters
- Summit, NJ
- Founded
- 2016
- Latest Form D
- $1.8M offered, Sep 2019
- Total capital
- $4.7M
- Federal grants
- $3M
- 7 awards · 2018–2022
- Rank in peer group#12 of 28
- Private capital raised
- $1.8M
- 2 Form D · last Sep 2019
- 85 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 1 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Non-Invasive Imaging of Oral Cavity Cancer$749K
- Federal grantHealth and Human S · Phase II · Non-Invasive Imaging of Oral Cavity Cancer$747K
- Federal grantHealth and Human S · Phase II · Non-Invasive Imaging of Oral Cavity Cancer$263K
- Offering registeredForm D · SEC · 2nd filing$1.8M
- Offering registeredForm D · SEC · 1st filing$500K
- Federal grantHealth and Human S · Phase I · Non-destructive and instant intraoperative margin assessment of high grade dysplasia and cancer of the cervix and vulva$300K
- Federal grantHealth and Human S · Phase I · Non-destructive and instant intraoperative margin assessment of high grade dysplasia and cancer of the cervix and vulva$300K
Show 2 earlier federal awards
- Federal grantHealth and Human S · Phase I · Rapid, quantitative and affordable point-of-care diagnostics for oral and oropharyngeal cancer$300K
- Federal grantHealth and Human S · Phase I · Rapid, quantitative and affordable point-of-care diagnostics for oral and oropharyngeal cancer$300K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
9months
from SUMMIT BIOMEDICAL IMAGING LLC’s first federal award to its first private round.
- First federal award · Sep 2018
- Health and Human S · $300K
- First Form D · Jun 2019
- $500K · 1st Form D
- Awards before first raise
- 4 awards
An association in public records, not a cause or a prediction.
Standing among 28 peers
Line = medianMedtech · Molecule
- Federal grants#12 · top 43%
- Linked publications#4 · top 14%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Christian E BrandResearcherExecutive OfficerLinked by $3M in grants as PI
- Andrew E RileyExecutive OfficerNamed in SEC Form D filings
- Robert E UnnoldDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 1- PendingPARPi-FL FormulationsUSPTOApplication 63211049
Recent research by its founders
- Flow cytometry in oral cytology: Improved brush biopsy-based delineation of oral malignant and potentially malignant lesions20260 cites
- Data from Safety and Feasibility of PARP1/2 Imaging with <sup>18</sup>F-PARPi in Patients with Head and Neck Cancer20230 cites
- Supplementary Data from Safety and Feasibility of PARP1/2 Imaging with <sup>18</sup>F-PARPi in Patients with Head and Neck Cancer20230 cites
Related companies, and why
- ClearCut Surgical, Inc.Similar federal contract value in Medtech · null in contracts
- BioWound Solutions, LLCSimilar federal contract value in Medtech · null in contracts
- Identifeye HealthSimilar federal contract value in Medtech · null in contracts
- New Day Diagnostics LLCSimilar federal contract value in Medtech · null in contracts
- Lightfield Medical, Inc.Similar federal contract value in Medtech · null in contracts
- RAM MEDICAL INNOVATIONS, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .